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Introduction
Mammalian ovarian follicles are highly specialised structures
that support the growth and development of oocytes.
Folliculogenesis results from a complex balance between
proliferation, differentiation and cell death, of both the somatic
and germ cell compartments of the follicle. Follicles leave the
resting primordial follicle pool and continue to grow, although
only very small numbers of follicles ever ovulate. Instead, most
ovarian follicles degenerate and die by the process of follicular
atresia. In fact, more than 99% of all ovarian follicles in the
cow are destined never to ovulate, but undergo atresia at
various stages of follicular development (Mariana et al., 1991).
In antral bovine follicles, the earliest and most prominent
feature of atresia is death of the granulosa cells, eventually
leading to total destruction of the granulosa cell layer lining
the inner follicle wall (Irving-Rodgers et al., 2001; Jolly et al.,
1994). Jolly et al. demonstrated, using biochemical methods,
that granulosa cell death during follicular atresia occurs by the
active process of programmed cell death or apoptosis (Jolly et
al., 1994). Van Wezel et al. reported that granulosa cells within
the middle layers of the membrana granulosa undergo
apoptosis, whereas granulosa cells closer to the follicular
antrum die via an alternative pathway as a result of terminal
differentiation (Van Wezel et al., 1999). At the cellular level,
apoptosis is characterized by cytoplasmic and nuclear
fragmentation, chromatin condensation, DNA fragmentation
and phagocytosis (Hardy, 1999). Nuclear changes typical for
early stage apoptosis include DNA fragmentation, which can
be detected using terminal deoxynucleotidyl transferase biotin-
dUTP nick-end labeling (TUNEL).
In the ovary, gonadotrophins and local growth factors have
been shown to be regulators of granulosa cell apoptosis. FSH
suppresses follicular cell apoptosis in murine pre-antral, early
antral and pre-ovulatory follicles (Chun et al., 1994; Chun et
al., 1996), and in cultured bovine granulosa cells (Yang and
Rajamahendran, 2000). In ovarian antral follicles, there are two
major phenotypes of granulosa cells that are anatomically and
functionally distinct: mural granulosa cells, which line the wall
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Paracrine factors secreted by the oocyte regulate a broad
range of cumulus cell functions. Characteristically,
cumulus cells have a low incidence of apoptosis and we
proposed that this is due to oocyte-secreted factors acting
in an anti-apoptotic manner. Bovine cumulus-oocyte
complexes (COC) were aspirated from abattoir-derived
ovaries and oocytectomized (OOX) by microsurgical
removal of the oocyte. OOX were treated with doses of
either denuded oocytes (DO) or various growth factors for
24 hours (± rFSH; 0.1 IU/ml). Proportions of apoptotic
cumulus cells were assessed using TUNEL and laser
confocal scanning microscopy followed by image analysis.
Quantification of Bcl-2 and Bax proteins in OOX was
undertaken by western analysis. Oocyte removal led to a
significant increase in cumulus cell apoptosis compared
with COC controls (35% versus 9% TUNEL positive,
respectively; P<0.001). Levels of OOX apoptosis were
significantly reversed (P<0.001) in a dose-dependent
manner when co-cultured with oocytes. Furthermore, the
anti-apoptotic effect of oocyte-secreted factors followed
a gradient from the site of the oocyte(s). Growth
differentiation factor 9 (GDF9) had no significant effect on
cumulus cell apoptosis. By contrast, cumulus cell apoptosis
was significantly (P<0.001) reduced by bone morphogenetic
proteins (BMP) 15, 6 or 7. Accordingly, levels of anti-
apoptotic Bcl-2 were high in OOX+DO and OOX+BMP15
and low with OOX+GDF9 or OOX alone, whereas the
reverse was observed for pro-apoptotic Bax. DO, BMP15
and BMP6 were also able to protect cumulus cells from
undergoing apoptosis induced by staurosporine. FSH
partially prevented apoptosis in all treatment groups
(P<0.001). Follistatin and a BMP6 neutralizing antibody,
which antagonized the anti-apoptotic effects of BMP15 and
BMP6, respectively, whether alone or combined, blocked
~50% of the anti-apoptotic actions of oocytes. These results
are the first to demonstrate that oocyte-secreted factors,
and particularly BMP15 and BMP6, maintain the low
incidence of cumulus cell apoptosis by establishing a
localized gradient of bone morphogenetic proteins.
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of the follicle; and cumulus cells, which surround and are in
intimate metabolic contact with the oocyte, forming the
cumulus-oocyte complex (COC). Apoptosis can be initiated in
at least four different cellular compartments of the antral
follicle: theca cells; granulosa cells; cumulus cells; and in the
oocyte itself. The first signs of ‘classical’ or antral atresia of
follicles are degeneration of the mural granulosa cells, which
lose their aromatase activity and undergo apoptosis (Irving-
Rodgers et al., 2001). Later, the theca cells undergo
hypertrophy and their androsterone production decreases
(Driancourt et al., 1998). The cumulus cells and the oocyte are
only affected in the most advanced stages of follicular atresia
(Kruip and Dieleman, 1982; Leibfried and First, 1979). As
such, during atresia of antral follicles, it is common for mural
granulosa cells to be undergoing apoptosis whilst cumulus
cells remain healthy within the same follicle (Yang and
Rajamahendran, 2000). The mechanism by which oocytes and
cumulus cells escape apoptosis is entirely unknown.
Cumulus cells surround and communicate with the oocyte
via paracrine factors and through gap junctions (Albertini et
al., 2001). Disruption of this communication axis reduces
cumulus cell proliferation and induces apoptosis in both cell
types (Luciano et al., 2000). The distinct phenotype of cumulus
cells is maintained by oocytes via the secretion of paracrine
growth factors that regulate a broad range of cumulus cell
functions (Eppig et al., 1997; Li et al., 2000). Oocyte-secreted
factors promote cumulus cell growth, regulate inhibin synthesis
while suppressing steroidogenesis and luteinizing hormone
receptor expression (reviewed in Gilchrist et al., 2004a).
Currently there is no data available as to whether these oocyte
factors may also regulate and maintain the low incidence of
cellular apoptosis within cumulus cells.
The mechanisms by which oocytes regulate cumulus cell
functions, including the identities of the oocyte-secreted
factors, remain largely unknown. Members of the
transforming growth factor- (TGF-) superfamily are
candidate oocyte-secreted molecules due to their ability to
mimic the actions of an oocyte on cumulus cells and granulosa
cells in vitro (Gilchrist et al., 2004a); in particular growth
differentiation factor-9 (GDF-9), bone morphogenetic protein-
15 (BMP-15), also referred to as GDF-9B, and BMP-6, all
three of which are expressed by the oocyte. BMPs have only
recently become recognised as autocrine/paracrine regulators
of ovarian follicular development, even though it is well
known BMPs regulate growth and differentiation in a broad
range of other tissues (Shimasaki et al., 2004). For example,
it is known that BMP-7 inhibits apoptosis in several tissues
including eye and kidney, and plays a role in skeletal
patterning (Dudley et al., 1995; Luo et al., 1995). Recent
evidence suggests that BMPs may have a role in regulating
ovarian atresia, as a dramatic decrease in the expression of
BMP-4, -7, and -3b is a feature of atresia (Erickson and
Shimasaki, 2003). As oocytes express BMP-15 and BMP-6,
these oocyte-secreted factors may play a role in preventing
follicular atresia. Several binding proteins antagonize BMP
actions, including follistatin, noggin and gremlin (Balemans
and Van Hul, 2002; Canalis et al., 2003). Although evidence
is so far lacking, it seems plausible that one mode of regulation
of the actions of these oocyte factors on cumulus cells may be
by BMP antagonists expressed in the follicle, such as gremlin
and follistatin, as well as by interaction with related follicular
BMPs, such as BMP-4 and BMP-7, utilising common receptor
and signalling pathways.
This study was conducted to investigate the nature of cellular
interactions within the ovarian follicle that are responsible
for maintaining the distinctive COC microenvironment. We
hypothesized that cumulus cells exhibit a low incidence of
apoptosis due to their close association with oocytes and their
exposure to oocyte-secreted factors. Experiments were
designed to determine the effect of oocyte-secreted factors on
cumulus cell apoptosis in the presence and absence of FSH,
and to examine the nature of the paracrine network of BMP
growth factors and their binding proteins regulating cumulus
cell apoptosis.
Materials and Methods
Collection of bovine oocytes and culture conditions
Unless otherwise specified, all chemicals and reagents were purchased
from Sigma (St Louis, MO). Bovine ovaries were collected from local
abattoirs and transported to the laboratory in warm saline (30-35°C).
COC were aspirated from antral follicles (2-8 mm diameter) using an
18-gauge needle and a 10 ml syringe containing ~2 ml aspiration
media (Hepes-buffered Tissue Cultured Medium-199; TCM-199, ICN
Biochemicals, Irvine, CA, USA) supplemented with 50 g/ml
kanamycin (Sigma-Aldrish, St Louis, MO), and 4 mg/ml fatty acid-
free bovine serum albumin (FAF-BSA; ICPbio Ltd, Aukland, NZ).
Intact COC with compact cumulus vestments greater than five cell
layers and evenly pigmented cytoplasm were selected under a
dissecting microscope and washed twice in Hepes-buffered TCM-199
and once in corresponding culturing media. Complexes were cultured
with or without 0.1 IU/ml recombinant human FSH (Organon,
Netherlands) in pre-equilibrated 50 l drops of culture media
(bicarbonated-buffered TCM-199 supplemented with 0.23 mmol
sodium pyruvate per litre and 0.3 mg/ml polyvinyl alcohol) overlaid
with mineral oil and incubated at 39°C with 5% CO2 in humidified
air for 24 hours. 
Treatment of cumulus cells
Generation of oocytectomized complexes
The cytoplasm of each oocyte was microsurgically removed from the
COC (oocytectomy) using a micromanipulator as described in
Buccione et al. (Buccione et al., 1990). The resulting oocytectomized
complex (OOX) consists of a hollow zona pellucida surrounded by
several layers of intact cumulus cells.
Generation of denuded oocytes
Denuded oocytes (DO) were generated by removing cumulus cells
from COC by vortexing for ~4 minutes in 2 ml H-TCM-199/BSA.
Any remaining cumulus cells were removed by repeated passage of
the oocytes through a fine-bore fire-polished glass pipette in H-TCM-
199/BSA.
Growth factors and binding proteins
Recombinant mouse GDF-9 and recombinant ovine BMP-15 were
produced in-house as previously described (Kaivo-Oja et al., 2003;
McNatty et al., 2005) using transfected 293 human embryonic kidney
cell lines (293H), generously donated by Olli Ritvos (Biomedicum,
Helsinki, Finland). Recombinant proteins were partially purified using
hydrophobic interaction chromatography (HIC), as recently described
(Hickey et al., 2005), and their concentrations were then estimated by
western blot (Kaivo-Oja et al., 2003; McNatty et al., 2005). Control
conditioned medium (293H) was also produced from untransfected
293H cells and purified by HIC. Recombinant human BMP-6,











5259Oocyte-secreted factors regulate cumulus cell apoptosis
recombinant human BMP-7, BMP-6 neutralizing antibody, and
gremlin were obtained from R&D systems (Minnaepolis, MN).
Follistatin-288 was generously donated by S. Shimasaki (University
of California, San Diego, USA) and R. Rodgers (The University of
Adelaide, Adelaide, Australia).
Determination of DNA damage by TUNEL (assessment of
cumulus cell apoptosis)
Cumulus cell apoptotic DNA was detected using TUNEL (Roche
Diagnostic, Penzberg, Germany) according to the manufacturer’s
instructions. Briefly, following culture COC and OOX complexes
were washed twice in PBS (pH 7.4) containing 1% BSA, fixed in 4%
paraformaldehyde in PBS (pH 7.4) overnight at 4°C and washed twice
with PBS/BSA before placing on Cell-Tak-coated coverslips (Beckton
Dickinson Biosciences, Franklin Lakes, NJ). Complexes were then
permeabilized in 0.1% Triton X-100 in 0.1% sodium citrate for 1 hour
at room temperature and washed three times in PBS/BSA. The
complexes were then incubated in fluorescein-conjugated dUTP and
terminal deoxynucleotide transferase (TUNEL reagents, Roche) for 1
hour at 37°C in the dark. Positive controls were incubated in DNAse
1 (0.005 U/l), which cleaves all DNA, for 20 minutes at room
temperature and washed twice in PBS/BSA before TUNEL. Negative
controls were incubated in fluorescein-dUTP in the absence of TdT.
After TUNEL, complexes were washed twice in PBS/BSA and
counterstained with propidium iodide 0.5 g/ml (PI) plus RNase A
(0.1 mg/ml) for 1 hour at room temperature in the dark to label all
nuclei. Complexes were then washed twice in PBS/BSA and mounted
with slight coverslip compression in VectaShield anti-bleaching
solution (Vector Labs, Burlingame, CA), and stored in the dark at 4°C
for confocal analysis.
Confocal microscopy and analysis
Apoptosis in COC and OOX was visualised and quantified using
confocal microscopy. Dual fluorescence emission from cumulus
cells was detected using a Nikon C1 Confocal Scanning Head
and a Nikon TE2000E microscope (Nikon, Tokyo, Japan).
Simultaneous emission capture of the apoptotic signal (fluorescein,
laser excitation 488 nm, emission 510-530 nm) and the nuclear
signal (propidium iodide, excitation laser 532, emission 590-640
nm) was performed.
To generate an accurate representation of the overall apoptotic
incidence for all complexes, the depth of each complex was
measured through a Z series to divide the construct into three
percentiles (optical Z plane sections) at 25%, 50% and 75%. These
optical section images were acquired and saved as independent
colour channels (green, apoptotic cumulus fluorescence and red,
nuclear cumulus fluorescence). The captured images were then
processed in Scanalytics IPLab software Version 3.6. (Scanalytics,
Fairfax, VA). Quantification of cumulus cell number (for each
colour channel) was independently measured using a macro script
utilizing an auto segmentation filter for each optical section
percentile (three optical ‘Z’-plane sections for each complex). A
percentage of apoptotic nuclei was generated for each slice and the
three percentile values were then averaged to achieve a
representation of the total apoptotic nuclei percentage for the whole
complex. These processes were repeated separately on each
individual complex.
Western blot analysis
Following culture treatments, OOX complexes were lysed in 25 l
RIPA lysis buffer [10 mM Tris (pH 7.4), 150 mM NaCl, 1 mM EDTA,
1% Triton X-100] and stored at –80°C. Thawed lysates were mixed
with 4 loading buffer containing 100 mM dithiothreitol (DTT)
and subjected to SDS-PAGE (12% polyacrylamide gel). Proteins
were subsequently electrotransferred to nitrocellulose membranes
(Hybond-ECL, Amersham Life Science, Ontario, Canada.) in 25 mM
Tris, 192 mM glycine containing 20% methanol. Blots were blocked
in 20 mM Tris (pH 7.6) containing 13.7 mM NaCl, 1% Tween-20,
and 2% blocking agent (provided in ECL Advance Kit) for 1 hour at
RT, then incubated overnight with Bcl-2 or Bax rabbit polyclonal
antibodies (0.35 g/ml; Santa Cruz Biotechnology, CA, USA) at 4°C,
followed by incubation with horseradish peroxidase-conjugated
anti-rabbit antibody (1:200,000; Silenus Laboratories, Melbourne,
Australia) and detected using the sensitive Enhanced
Chemiluminescence (ECL) Advance system (Amersham Biosciences,
Ontario, Canada). Images were then scanned using a flat bed scanner
and the intensity of Bcl-2 and Bax bands in each sample was
quantitated by the ImageJ Imaging System Software version 1.3
(National Institutes of Health, USA).
Experimental design
Experiment 1: the effect of oocytectomy on cumulus cell
apoptosis
The aim of this experiment was to determine whether intact COC have
a different level of apoptosis to OOX. Groups of five COC or OOX
were cultured in 50 l drops of culture media for 24 hours before
apoptosis was assessed. Six replicate experiments were performed. 
Experiment 2: the effect of oocyte-secreted factors on
cumulus cell apoptosis
To determine whether oocyte-secreted factors are responsible for the
low incidence of apoptosis in cumulus cells of intact COC, OOX were
cultured with increasing numbers of denuded oocytes and compared
with COC. 5, 25 or 50 denuded oocytes were added to 50 l culture
drops containing 5 OOX. Three replicate experiments were
performed.
Experiment 3: pattern of apoptosis in relation to proximity to
oocyte-secreted factors origin
The aim of this experiment was to determine the distribution of
apoptosis within the cumulus cell complex in relation to the
complex’s proximity to the oocyte. We quantified the apoptotic
incidence in COCs, where the origin of the oocyte-secreted factors
is central to the cumulus cell complex, and in contrast, in OOXs co-
cultured with denuded oocytes, where the origin of the oocyte-
secreted factors is on the outside of the cumulus cell complex. OOXs
cultured alone were used as a control, and all complexes were
cultured without FSH. Using the confocal microscope, the diameter
of complexes was measured after the diameter of the oocyte region
was subtracted using Scanalytics IPLab software Version 3.6. This
was then divided into three equal layers; inner, middle and outer
cumulus cell layers, forming three ring zones around the oocyte.
Each layer was equivalent to a proportion of 33% of the total radius.
The incidence of apoptosis was then analysed independently in each
layer.
Experiment 4: dose response of GDF-9, BMP-6 and BMP-
15 on cumulus cell apoptosis
In an attempt to examine which of the putative oocyte-secreted
factors is contributing to the low incidence of apoptosis observed in
COC, OOX were cultured with increasing concentrations of either
GDF-9 (0-175 ng/ml), BMP-6 (0-100 ng/ml) or BMP-15 (0-20%
v/v), either in the absence or presence of FSH. OOX were also
treated with 10% (v/v) 293H, which served as a parent cell line-
conditioned media negative control for GDF-9 (equivalent to 132
ng/ml) and 10% (v/v) BMP-15. Three replicates of these













Experiment 5: the effect of oocytes, GDF-9 and
BMP-15 on cumulus cell expression of Bcl-2 and
Bax proteins
This experiment was conducted to confirm that treatment
effects on cumulus cell apoptosis, as assessed by TUNEL,
are concomitant with changes in expression of key proteins
regulating cell death and survival. OOX were cultured for
24 hours untreated, or treated with 132 ng/ml GDF-9, 10%
BMP-15, co-cultured with 35 denuded oocytes per well, or
10% 293H (control conditioned medium), and then
subjected to western blot for analysis of Bcl-2 and Bax
expression.
Experiment 6: effect of oocytes, BMP-6 and BMP-
15 on cumulus cell apoptosis induced by
staurosporine
A preliminary experiment was conducted to determine the
apoptotic effect of staurosporine on bovine cumulus cells,
which induced apoptosis in a dose-dependent manner
(range; 0.1-100.0 M, data not shown). The aim of this
experiment was to determine whether oocyte-secreted
factors could prevent cumulus cells from undergoing
apoptosis induced by staurosporine. OOX alone or co-
cultured with 35 denuded oocytes, 10 ng/ml BMP-6 or 10%
BMP-15, were then exposed to either 0.1 M or 1.0 M
staurosporine for the last 6 hours of the 24 hour incubation
period. Three replicates of this experiment were carried out
using 10 OOX per treatment group per replicate experiment.
Experiment 7: effect of BMP antagonists on cumulus cell
apoptosis
Follistatin binds to both BMP-15 and activin with high affinity and
antagonizes their bioactivity (Lin et al., 2003; Otsuka et al., 2001).
Gremlin is expressed in both mural granulosa cells and cumulus cells
and selectively blocks BMP-4 and BMP-7 (Merino et al., 1999), and
may antagonize BMP-15. The aim of this experiment was to examine
the effectiveness of these antagonists against BMP-6 and BMP-15-
prevented cumulus cell apoptosis. OOX were cultured with 10%
BMP-15 in the presence of increasing doses of follistatin (0-100
g/ml) or in the presence of increasing doses of gremlin (0-40 g/ml).
In a separate experiment, OOX were treated with 10 ng/ml BMP-6 in
the absence or presence of a high dose (20 g/ml) of a BMP-6
monoclonal neutralizing antibody (NAb). Three replicates of each of
these experiments were carried out using 10 OOX per treatment group
per replicate experiment.
Experiment 8: role of BMP-15 and BMP-6 in the anti-
apoptotic actions of oocytes on cumulus cells
In an attempt to neutralize the anti-apoptotic bioactivity of oocytes on
cumulus cells, OOX were co-cultured with 25 denuded oocytes, either
in the absence or presence of 50 g/ml follistatin, 20 g/ml BMP-6
NAb, or in the presence of both antagonists. A separate experiment
was conducted to examine any additive effects of BMP-15 and BMP-
6, compared with OOX+oocytes. OOX were treated with denuded
oocytes, or with 10 ng/ml BMP-6 and/or 10% BMP-15. Three
replicates of these experiments were carried out using 10 OOX per
treatment group per replicate experiment.
Experiment 9: effect of BMP-7 and its antagonist, gremlin,
on cumulus cell apoptosis
To examine the influence of BMP-7 and its antagonist, gremlin, on
cumulus cell apoptosis, OOX were treated with 100 ng/ml BMP-7
and/or 10% BMP-15 in the presence or absence of 2 g/ml gremlin.
Three replicates of this experiment were carried out using 10 OOX
per treatment group per replicate experiment.
Statistical analysis
Frequencies of cumulus cell apoptosis were analysed by ANOVA
using SigmaStat software (SPSS Inc, Chicago, IL), and significant
differences between means were determined using Tukey-Kramer
post-hoc test for comparison of multiple means. All cell proportional
Journal of Cell Science 118 (22)
Fig. 1. Representative images of confocal laser scanning
microscopy of DNA fragmentation in cumulus cells, as
detected by TUNEL (green label). All cell nuclei are also
stained with propidium iodide (red). Positive control
DNAse 1-treated OOX showed very strong apoptotic
staining (99%) (A), negative control did not reveal any
apoptotic signals (0%) indicating specific labelling (B),
expanded COC after culture with low apoptotic labelling
(9%) (C), compared with OOX with higher apoptotic
labelling (35%) (D). Light micrograph of an unexpanded
intact COC before culture (E) and a denuded oocyte (F),
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data were arc-sine transformed prior to analysis. Differences were
considered statistically significant at P<0.05.
Results
Experiment 1: the effect of oocytectomy and FSH on
cumulus cell apoptosis  
TUNEL coupled with confocal scanning microscopy proved a
highly effective means of visualising and quantifying cumulus
cell apoptosis. TUNEL positive and negative controls (Fig.
1A,B) (99% and 0% apoptosis, respectively) demonstrated
specificity. COCs exhibited a low incidence of cumulus cell
apoptosis (9%; Fig. 1C), and removal of the oocyte led to a
significant increase to 35% in OOXs (P<0.001; Fig. 1D). As is
expected with bovine cumulus cells, treatment with FSH
induced cumulus expansion in both COCs and OOXs (Fig.
1C,D), and significantly decreased the incidence of apoptosis
in OOXs (by 10%) and in COCs (by 6%) (P<0.001) (Fig. 2).
Experiment 2: the effect of oocyte-secreted factors on
cumulus cell apoptosis  
To determine if oocyte paracrine factors are responsible for low
COC apoptosis, an attempt was made to reduce the incidence
of apoptosis in OOX to COC levels, by co-culturing OOXs
with increasing concentrations of denuded oocytes. Cumulus
cell apoptosis was significantly reduced (P<0.001), in a dose-
dependent manner, by incubating OOXs with increasing
numbers of oocytes. Apoptotic levels in OOXs were
completely restored to COC levels at the maximum number of
oocytes (50 DO per well), whether in the presence or absence
of FSH (Fig. 2). These results indicate that oocyte-secreted
factors prevent apoptosis within cumulus cells.
Experiment 3: pattern of apoptosis in relation to
proximity to oocyte-secreted factor origin
Qualitative observations of confocal images suggested that the
apoptotic cells within COCs were mostly distributed to the
outer layer of complexes, whereas apoptosis was observed in
Fig. 2. A dose response of oocyte-secreted factors on cumulus cell
apoptosis in the absence (A) or presence (B) of FSH. Oocytectomized
complexes (OOX) were cultured with increasing numbers of denuded
oocytes (DO) and at the maximum dose were effective at reducing
apoptosis to the control COC levels. FSH also significantly reduced
apoptosis in COCs and OOXs. Points represent average percentage of
apoptotic cumulus cells (mean ±s.e.m.). Values from points with
different labels; a,b,cdiffer significantly (P<0.001).
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Fig. 3. Pattern of apoptosis within cumulus complexes in relation to
proximity to oocyte-secreted factor origin. Diameters of unexpanded
COCs and OOXs were measured after culture without FSH, using
confocal microscopy and divided into three layers: inner, middle and
outer layers. Each layer representing 33% of the radius (A). The
incidence of apoptosis was lowest closest to the oocyte, regardless of
whether the oocyte was inside the complex [(C), COC inner layer] or
oocytes were on the outside of the complex [(D), OOX outer layer],
and apoptosis increased with increasing distance from the oocyte (B).
Both C and D images are exaggerated examples to illustrate pictorially
the morphogenic gradient of apoptosis through the cumulus cell layers.












the inner cumulus layers when OOXs were co-cultured with
denuded oocytes. We therefore hypothesized that oocyte-
secreted factors establish an anti-apoptotic morphogenic
gradient through the cumulus cell layers. To test this
hypothesis, we measured the diameter of COC and OOX
complexes and then divided them into three layers: inner,
middle and outer (Fig. 3A). Within COCs, which contain an
intact oocyte, the incidence of apoptosis increased significantly
(P<0.026) from the inner layer toward the outer layer (Fig.
3B,C). Conversely, when OOXs were co-cultured with
denuded oocytes, the incidence of apoptosis decreased from
the inner layer toward the outer layer, which is closest to the
source of oocyte-secreted factors (Fig. 3B,D). To illustrate this
effect further, the inner layer in COC, which is closest to the
oocyte and has the lowest incidence of apoptosis, has a fourfold
and significantly (P<0.026) lower incidence of apoptosis,
compared with its counterpart inner layer from the OOX+DO
group, which has the highest incidence of apoptosis, being the
furthest layer from the oocytes (Fig. 3B). To examine the effect
of the oocytectomy procedure itself and the associated loss of
oocyte-cumulus cell gap junctional communication, apoptosis
was analysed in OOX cultured alone for 24 hours. Apoptosis
were equally distributed in the three layers; inner, middle and
outer (49.5, 49.9 and 45.5%, respectively; P>0.05).
Experiment 4: dose response of GDF-9, BMP-6 and
BMP-15 on cumulus cell apoptosis
These experiments were conducted to determine the effect of
these putative oocyte-secreted factors on the regulation of
cumulus cell apoptosis. OOX complexes were treated with
increasing doses of GDF-9, BMP-6 and BMP-15. GDF-9
had no significant effect on the incidence of cumulus
cell apoptosis in the presence or absence of FSH, as at the
highest dose (175 ng/ml) of GDF-9, apoptosis was not
significantly different to the 293H control conditioned
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Fig. 4. Dose response of the
putative oocyte-secreted factors;
GDF-9, BMP-6, BMP-15 on
cumulus cell apoptosis. OOX were
cultured with increasing
concentrations of GDF-9 (0-175
ng/ml), BMP-6 (0-100 ng/ml), and
BMP-15 (0-20% v/v), either in the
absence (A,C,E) or presence
(B,D,F) of FSH. Cumulus cell
apoptosis was unaffected by GDF-
9 and attenuated in a dose-
dependent manner by BMP-6, but
more notably by BMP-15. FSH
independently attenuated
apoptosis regardless of treatment
or complex type. Points represent
average percentage of apoptotic
cumulus cells (mean ±s.e.m.).
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medium group (Fig. 4A,B). With an increasing dose of BMP-
6, cumulus cell apoptosis significantly decreased (P<0.001),
whether in the presence or absence of FSH (Fig. 4C,D).
Cumulus cell apoptosis was significantly reduced (P<0.001)
in a dose-dependent manner, by treating OOX with an
increasing dose of BMP-15, having maximal effect at 20%
BMP-15 (Fig. 4E). A similar response was observed when
BMP-15 was used in combination with FSH (Fig. 4F).
Consistent with experiment 2, FSH had an additive effect in
preventing cumulus cell apoptosis, independently decreasing
the incidence regardless of growth factor treatment or
complex type.
Experiment 5: the effect of oocytes, GDF-9 and BMP-15
on cumulus cell expression of Bcl-2 and Bax proteins
This experiment was conducted to study the pattern of Bcl-2
and Bax expression in cumulus cells of OOX complexes.
Expression of Bcl-2 protein was significantly (P<0.001) higher
in cumulus cells when OOX were co-cultured with denuded
oocytes and BMP-15 compared with when untreated or treated
with GDF-9 (Fig. 5). By contrast, expression of Bax protein
was found to be significantly (P<0.001) higher in cumulus
cells when OOX were untreated or co-cultured with GDF-9
compared with OOX co-cultured with denuded oocytes or
BMP-15, where Bax levels were barely detectable (Fig. 5).
These results support our TUNEL results, namely that oocytes
and BMP-15 but not GDF-9 are associated with the prevention
of cumulus cell apoptosis, and that oocytes and BMP-15 alter
the ratio of Bcl-2 to Bax in favour of cell survival (Oltvai et
al., 1993), whereas GDF-9 has no effect on the Bcl-2 to Bax
ratio.
Experiment 6: protection of cumulus cells from
staurosporine-induced apoptosis by oocytes, BMP-6
and BMP-15
The aim of this experiment was to determine whether oocytes
are capable of protecting cumulus cells from an apoptosis-
inducing event and whether such an effect can by mimicked by
BMP-15 and BMP-6. Staurosporine significantly increased
(P<0.001) the incidence of cumulus cell apoptosis from
41% to 51% and 74% when treated with 0.1 and 1.0 M,
respectively (Fig. 6). The apoptosis-inducing effects of both
doses of staurosporine were completely negated when
staurosporine-treated OOXs were co-cultured with denuded
oocytes, with apoptosis reduced to COC levels. Also, OOX
treated with 10% BMP-15 or 10 ng/ml BMP-6, exposed to the
same two doses of staurosporine, showed significantly
decreased apoptosis; 17% and 21% (0.1 M); 25% and 31%
(1 M), respectively (P<0.001). These results indicate that the
anti-apoptotic actions of oocyte-secreted factors can protect
cumulus cells from an apoptotic insult and that both BMP-15
and BMP-6 can mimic this effect.
Experiment 7: effect of BMP antagonists on cumulus cell
apoptosis
These experiments were conducted to examine whether BMP-
15 and BMP-6 antagonists could neutralize the anti-apoptotic
effects of BMP-15 and BMP-6 on cumulus cell apoptosis.
There was a significant (P<0.001), dose-dependent increase
in apoptosis when BMP-15-treated OOXs were cultured with
increasing concentrations of follistatin (Fig. 7A). OOX
complexes cultured with 10 ng/ml BMP-6 were treated with a
high dose (20 g/ml) of a BMP-6 neutralizing antibody. Fig.
7B illustrates that the BMP-6 antagonist significantly
(P<0.001) neutralized the anti-apoptotic effect of 10 ng/ml
BMP-6.
Fig. 5. Effect of denuded oocytes (DO), GDF-9 and BMP-15 on
OOX expression of Bcl-2 and Bax proteins as examined by western
blot analysis. Groups of 35 OOX were loaded in each lane after the
following treatments: lane 1, 10% v/v 293H (control conditioned
medium); lane 2, control (OOX alone); lane 3, 132 ng/ml GDF-9;
lane 4, 10% v/v BMP-15; lane 5, 0.7 DO/ l. Band intensities were
quantified by densitometry and are expressed relative to the 293H
control, from three replicate experiments (mean ±s.e.m.). Bars with
different superscripts within a group (a,bBcl-2, y,zBax) are
significantly different (P<0.001).
Fig. 6. Protection of cumulus cells from staurosporine-induced
apoptosis by denuded oocytes (DO), BMP-6 and BMP-15. OOX
alone or co-cultured with 35 DO, 10 ng/ml BMP-6, or 10% v/v
BMP-15, were exposed to either 0.1 M or 1.0 M staurosporine
(STS) in the last 6 hours of incubation. Oocytes, BMP-6 and BMP-
15 all prevented staurosporine-induced cumulus cell apoptosis.
Asterisks represent OOX means significantly different (P<0.001)
relative to the OOX control.
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Experiment 8: role of BMP-15 and BMP-6 in the anti-
apoptotic actions of oocytes on cumulus cells
To determine if the anti-apoptotic effects of oocytes on
cumulus cells can be attributed to either BMP-15 and/or BMP-
6, an attempt was made to neutralize oocyte-secreted factors
using follistatin with and without a BMP-6 NAb. Fig. 8A
illustrates that OOX co-cultured with oocytes have a reduced
incidence of cumulus cell apoptosis compared with OOX
alone, which was comparable to the COC control. Either
follistatin alone or the BMP-6 NAb alone significantly
antagonized ~50% of the anti-apoptotic effects of oocytes on
cumulus cells (P<0.001). The effects of follistatin and the
BMP-6 NAb were not additive as their combined presence did
not further restore apoptosis levels. 
The results from Fig. 8A suggested that oocyte-secreted
BMP-15 and BMP-6 act redundantly to prevent cumulus cell
apoptosis, and as such, should not act in an additive fashion.
An experiment was conducted to test this proposal. Co-
culturing OOX with denuded oocytes or treatment with BMP-
15 alone or BMP-6 alone significantly (P<0.001) decreased
cumulus cell apoptosis (Fig. 8B). Combined treatment of
OOXs with BMP-6 and BMP-15 did not further decrease
apoptosis levels beyond that of BMP-15 alone (P>0.05),
suggesting no additive effect of these two BMPs.
Experiment 9: Effect of BMP-7 and its antagonist,
gremlin, on cumulus cell apoptosis
This experiment was conducted to determine the effect of
adding BMP-7 and its antagonist, gremlin, in the presence of
BMP-15, on the regulation of cumulus cell apoptosis. BMP-7
and BMP-15 significantly reduced cumulus cell apoptosis
(P<0.001) (Fig. 9). The anti-apoptotic effects of BMP-15 were
Journal of Cell Science 118 (22)





























































Fig. 7. Effect of BMP antagonists on cumulus cell apoptosis. OOX
were cultured with 10% v/v BMP-15 in the presence of increasing
doses of follistatin (0-100 g/ml) (A), and OOX were cultured with
10 ng/ml BMP-6 in the absence or presence of a high neutralizing
dose of 20 g/ml of a BMP-6 neutralizing antibody (NAb) (B).
Suppression of cumulus cell apoptosis by BMP-15 was antagonized
by follistatin. The NAb effectively antagonized the anti-apoptotic
effects of BMP-6. Points and bars represent average percentage of
apoptotic cumulus cells (mean ±s.e.m.). Values from points with
different labels; a,b,cdiffer significantly (P<0.001).
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Fig. 8. Role of BMP-15 and BMP-6 in the anti-apoptotic actions of
oocytes on cumulus cells. OOX co-cultured with denuded oocyte (25
DOs) were treated with 50 g/ml follistatin, 20 g/ml BMP-6 NAb,
or a combination of the two (A). Both follistatin and the BMP-6 NAb
were effective at partially antagonizing the anti-apoptotic effects of
oocytes, however neither completely restored apoptosis to OOX
levels, either alone or combined. Co-culturing OOX with DO or
treatment with BMP-15 alone or BMP-6 alone decreased cumulus
cell apoptosis (B). Combined treatment of OOXs with BMP-6 and
BMP-15 did not further decrease apoptosis levels beyond that of
BMP-15 alone, suggesting no additive effect of these two BMPs.
Bars represent average percentage of apoptotic cumulus cells (mean
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unaffected by gremlin, including at high doses (Fig. 9A).
Conversely, 2 g/ml gremlin significantly (P<0.001) reversed
the inhibitory effect of 100 ng/ml BMP-7, but not when BMP-
15 was present (Fig. 9B). 
Discussion
The current study was undertaken to test the hypothesis that
ovarian cumulus cells exhibit a low incidence of apoptosis due
to their close association with oocytes and their exposure to
oocyte paracrine factors. This hypothesis was formulated based
on the observation that during atresia in antral follicles, the
COC is the last compartment of the ovarian follicle to undergo
atresia, which is primarily manifested as apoptosis in the mural
granulosa cell layer and, at later stages, in the theca cells
(Tajima et al., 2002; Yang and Rajamahendran, 2000). The
present study demonstrates that removal of the oocyte from the
COC by oocytectomy leads to a substantial increase in cumulus
cell apoptosis. However, low apoptosis levels can be restored
by co-culturing OOX with oocytes, which reduces the
incidence of apoptosis in a dose dependent manner, and which
is completely restored to COC levels at the maximum
concentration of 50 oocytes per well. These findings
demonstrate that the low level of cumulus cell apoptosis is
largely dependent on the presence of the oocyte. Furthermore,
the characteristically low incidence of cumulus cell apoptosis
can be specifically attributed to soluble paracrine signals from
the oocyte, rather than oocyte gap junctional signalling to
cumulus cells, since: (1) the paracrine effects of oocytes were
observed in a co-culture environment devoid of direct oocyte-
cumulus cell contact; and (2) disrupting oocyte-cumulus cell
gap junctional communication by oocytectomy led to a
homogenous increase in apoptosis in all cumulus cell layers,
not just in the inner layer, which has the highest junctional
contact with the oocyte.
The study demonstrates by various means that oocytes
actively prevent cumulus cell apoptosis by establishing a
morphogenic gradient of oocyte-secreted factors. Firstly, the
reduction in cumulus cell apoptosis was assessed by two
different methods: we used TUNEL together with quantitative
confocal microscopy, and also examined the expression of key
proteins regulating apoptosis by western blot. Exposure of
OOX to oocytes dramatically induced anti-apoptotic Bcl-2
expression. Conversely, pro-apoptotic Bax expression was high
in OOX alone and was notably reduced by oocyte-secreted
factors. These results suggest that oocytes prevent apoptosis
within cumulus cells by altering the ratio of Bax to Bcl-2 in
favour of cell survival. Secondly, the anti-apoptotic actions of
oocytes followed a gradient from the site of the oocyte(s). In
intact COCs, the incidence of apoptosis was lowest in the inner
most layer of cumulus cells and increased with increasing
distance from the oocyte. Conversely, in OOX+denuded
oocytes, where the oocytes are outside the complex and the
OOX is hollow, the outer layer of cumulus cells closest to the
oocytes had the lowest level of apoptosis. This is the first direct
evidence of a very localised morphogenic gradient of oocyte-
secreted factors in the COC, which was proposed some time
ago (Eppig, 2001). This gradient of oocyte-secreted factors is
likely to play a significant role in the spatial organisation and
functional characteristics of cumulus cells within the COC.
Thirdly, oocyte-secreted factors were able to protect cumulus
cells from an apoptotic insult. Staurosporine induces apoptosis
via a cellular signal cascade (to date uncharacterized) as
opposed to causing indiscriminate DNA damage (Weil et al.,
1996; Yuan et al., 2004). Oocyte-secreted factors prevented
apoptosis induced by staurosporine demonstrating that oocytes
are able to protect cumulus cells from an apoptosis-inducing
event. Together these results demonstrate that oocytes secrete
a potent anti-apoptotic factor(s) that acts in a very localised
manner.
Supplementation of media with FSH also decreased the
incidence of cumulus cell apoptosis in both COCs and OOXs.
This is consistent with other studies (Chun et al., 1996; Yang
and Rajamahendran, 2000) and with the notion that FSH is an
indispensable hormone driving follicular growth and that the
primary cause of follicular atresia is inadequate exposure to
FSH. It is also noteworthy that the anti-apoptotic effects of
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Fig. 9. Effect of BMP-7 and its antagonist gremlin on cumulus cell
apoptosis. OOXs were cultured with 10% v/v BMP-15 in the
presence of increasing doses of gremlin (0-40 g/ml) (A). OOX were
also co-cultured with 100 ng/ml BMP-7 and/or 10% BMP-15 in the
presence or absence of 2 g/ml gremlin (B). Gremlin did not
antagonize the suppressive effect of BMP-15 on cumulus cell
apoptosis, whereas it did that of BMP-7. Bars and points represent
average percentage of apoptotic cumulus cells (mean ±s.e.m.).













Evidence exists, now from many different groups, of the
many roles that oocytes play in regulating ovarian follicle
development. Oocyte-secreted factors regulate folliculogenesis
by modulating a broad range of functions associated with
growth and differentiation of granulosa/cumulus cells
(reviewed in Eppig, 2001; Gilchrist et al., 2004a). In general,
oocyte-secreted factors promote granulosa/cumulus cell
proliferation, particularly in synergy with local mitogenic
agents such as IGF-I and androgens (Hickey et al., 2005; Li et
al., 2000), and simultaneously prevent gonadotrophin-induced
differentiation and luteinisation. Adding to this developing
model, this study provides the first direct evidence that oocyte-
secreted factors also prevent cumulus cell apoptosis. Hence it
seems oocytes help stimulate cumulus cell growth by actively
preventing differentiation, while simultaneously providing a
protective mechanism against cell death and promoting cellular
DNA synthesis and proliferation.
Despite the dramatic and critical effects of oocyte-secreted
factors on cumulus cell functions, the exact identities of these
key oocyte molecules remains largely unknown. To date,
the best candidate molecules are members of the TGF
superfamily, in particular GDF-9 and BMP-15, which can
mimic many of the actions of oocytes on granulosa/cumulus
cells in vitro (Gilchrist et al., 2004a). It is interesting to note
that GDF-9 had no significant effect on the incidence of
cumulus cell apoptosis in the present study, despite the fact that
GDF-9 is an exceptionally potent granulosa cell mitogen
(Gilchrist et al., 2004b; Hayashi et al., 1999; Vitt et al., 2002).
Instead, cumulus cell apoptosis was markedly reduced by
BMP-15, BMP-6 and BMP-7, which in general are weak
mitogens. This study provides multiple lines of evidence that
BMP signalling, and not GDF-9 signalling, prevents cumulus
cell apoptosis: (1) all three BMPs tested reduced the incidence
of cumulus cell apoptosis in a dose-dependent manner; (2) both
BMP-6 and BMP-15 protected cumulus cells from apoptosis
induced by staurosporine; (3) expression of cumulus cell anti-
apoptotic Bcl-2 was stimulated by BMP-15 but not by GDF-
9; and in contrast, (4) pro-apoptotic Bax expression was
inhibited by BMP-15 but not by GDF-9. These findings support
the concept proposed by Oltvai et al. that the ratio of Bcl-2 to
Bax determines whether a cell lives or dies (Oltvai et al., 1993),
and that BMP-15 and BMP-6 can regulate that ratio.
There are two divergent signalling pathways activated by the
TGF superfamily; the BMP pathway and the TGF/activin
pathway. GDF-9 was recently shown to signal through the
ALK5 (Mazerbourg et al., 2004) and BMPRII (Vitt et al., 2002)
receptors, activating SMAD 2/3 molecules and hence eliciting
a TGF-like intracellular response (Kaivo-Oja et al., 2003;
Roh et al., 2003). Conversely, BMP-15, BMP-6 and BMP-7
have been shown to signal through ALK6 and BMPRII
receptors, thereby activating the alternate SMAD 1/5/8
pathway (reviewed by Shimasaki et al., 2004). Hence it seems
likely that bovine oocyte-secreted factors stimulate both
signalling pathways simultaneously in cumulus cells;
activation of the SMAD 1/5/8 pathway by BMP-15 and BMP-
6 transmitting the anti-apoptotic actions of the oocyte, and
activation of the alternate SMAD 2/3 pathway by GDF-9
conveying the oocyte’s mitogenic signal.
A further objective of the current study was to attempt to at
least partially identify the native oocyte-secreted factors
preventing cumulus cell apoptosis. This is most easily
achieved through experimental neutralization of the effects of
oocytes on cumulus cells, as actual purification of oocyte-
secreted factors has so far proved unfeasible. Several high-
affinity binding proteins antagonize BMP actions, including
follistatin and gremlin. Follistatin, which is highly expressed
by granulosa cells in developing follicles, inhibits the
biological activities of activins and BMP-15 by forming
inactive complexes (Otsuka et al., 2001; Shimasaki et al.,
2004). In the current study, follistatin and a BMP-6
neutralizing antibody were able to antagonize the anti-
apoptotic effects of BMP-15 and BMP-6, respectively.
Whereas gremlin, which is expressed in granulosa cells and
cumulus cells and is a known BMP-2, BMP-4 and BMP-7
antagonist (Sudo et al., 2004), did not antagonize the anti-
apoptotic actions of BMP-15.
We next went on to examine the capacity of the BMP
antagonists to neutralise the anti-apoptotic effects of the
oocyte. Follistatin or the BMP-6 neutralizing antibody alone
were able to partially antagonize the anti-apoptotic actions of
the oocyte, suggesting that this action by bovine oocytes can
be attributed in part to BMP-15 and/or BMP-6. These findings
describe an entirely novel function for these oocyte-secreted
molecules. BMP-15 and BMP-6 appear to act redundantly to
prevent cumulus cell apoptosis. The recombinant proteins did
not have an additive effect on apoptosis when added together,
and simultaneous neutralization of native oocyte BMP-15 and
BMP-6 did not increase the effect of neutralizing either alone.
These data provide the first direct evidence that endogenous
BMP-15 and BMP-6 oocyte proteins are important anti-
apoptotic oocyte-secreted factors, but also that these molecules
account for only part of the total anti-apoptotic activity of the
oocyte (~50%), the remaining portion of which is yet to be
determined. Candidate molecules may include other members
of the TGF superfamily, however it seems unlikely to include
the subfamily of TGFs and activins, as stimulation of their
SMAD 2/3 signalling pathway, as exemplified here by GDF-9,
has no effect on cumulus cell apoptosis. A putative oocyte-
secreted GDF-9/BMP-15 heterodimer may play some role in
regulating cumulus cell apoptosis, however at this stage, little
is known of this molecule or of its signalling pathway (Juengel
and McNatty, 2005).
BMPR-II is an indispensable receptor for the transmission
of the paracrine actions of oocytes to cumulus/granulosa cells,
as it is the sole type-II receptor for BMP-15 and GDF-9 and
an important receptor for BMP-6 (Shimasaki et al., 2004).
Efficacy of oocyte-secreted factors on cumulus cells would be
reduced if alternate non-oocyte-secreted factors ligands
expressed in the follicle that bind BMPR-II, such as BMP-7,
BMP-4 or BMP-2, competed for BMPR-II binding thereby
reducing its availability. In the present study, we show that
BMP-7 can mimic the action of oocyte-secreted BMP-15 or
BMP-6 in preventing cumulus cell apoptosis, even though it is
not an oocyte-secreted factor and is only expressed by theca in
the follicle (Lee et al., 2001). Gremlin is a BMP-binding
protein expressed by granulosa cells in response to GDF-9 and
BMP-4 which selectively inhibits certain BMPs without
affecting GDF9 (Pangas et al., 2004). Gremlin, which is known
to be highly effective at antagonizing BMP-2 and BMP-4
actions (Sudo et al., 2004), neutralized the anti-apoptotic effect
of BMP-7 but was ineffective against BMP-15 (present study).
As such, the anti-apoptotic actions on cumulus cells of the
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endogenous oocyte-product, BMP-15, were unaffected by the
combined presence of BMP-7 and gremlin. Such interactions
suggest an additional level of complexity of mechanisms
regulating communication between the oocyte and its
surrounding cumulus cells.
These results support and extend the model proposed by
Pangas et al. whereby gremlin modulates GDF9 and BMP
interactions (Pangas et al., 2004), which we propose are
crucial for maintenance of the highly specialized COC
microenvironment (see model) (Fig. 10). This extended model
hypothesizes that oocyte-GDF9 induces cumulus cell gremlin
expression, which in turn blocks theca and granulosa cell-
derived BMPs from competing with BMP-15 and GDF-9 for
BMPR-II binding. In addition, follistatin produced by mural
granulosa cells and present in follicular fluid, may limit the
anti-apoptotic effects of BMP-15 specifically to the COC.
Apoptosis and subsequent atresia of the mural granulosa cell
layer may be able to proceed despite the apparent presence of
BMP-15 in follicular fluid (McNatty et al., 2004), due to
follistatin neutralisation of BMP-15 at this site. This model
illustrates our hypothesis that oocytes actively prevent death
of cells in their immediate microenvironment only, by
establishing a morphogenic gradient of BMP-15 and BMP-6
emanating from the oocyte. This gradient of BMPs is either
sufficiently dilute and/or adequately neutralized outside the
COC microenvironment, such that mural granulosa cell
apoptosis and follicular atresia can proceed whilst the COC
remains relatively healthy. We hypothesize that this is the
mechanism whereby, in large mammals, the cumulus cells and
oocyte are the last cell types to die during advanced follicular
atresia.
Collectively, the evidence presented in this paper
demonstrates for the first time that oocytes, in particular the
oocyte-secreted factors BMP-6 and BMP-15, are responsible
for the low incidence of apoptosis within cumulus cells,
through the establishment of a paracrine network of BMP
growth factors and their binding proteins. Thus prevention of
cumulus cell apoptosis can be added to the growing
compendium of follicular cell functions regulated by oocytes.
This adds further support to the emerging doctrine that oocytes
secrete these paracrine factors to establish and maintain an
immediate microenvironment, which is distinct from that of the
rest of the follicle (Eppig, 2001; Gilchrist et al., 2004a).
Specific knowledge of GDF-9 and BMP interactions, and about
the spatial and temporal regulation of their native antagonists
is required, as regulation of this oocyte-cumulus cell
communication network will have physiological implications
for oocyte growth and development, oocyte maturation,
ovulation and developmental competence of the ensuing
embryo.
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